GreenLight Biosciences Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -2617%. Total operating expenses were $169,344,000.

Profit Margin

GreenLight Biosciences Holdings (NASDAQ:GRNA): Profit margin
2019 3.00M -28.96M -965.21%
2020 962K -54.27M -5642.31%
2021 0 -114.72M
2022 6.38M -167.05M -2616.78%

GRNA Income Statement (2019 – 2022)

2022 2021 2020 2019
Revenue
Revenue
6.38M0962K3.00M
Cost of revenue
0000
Gross profit
6.38M0962K3.00M
Operating exp.
Research and development
133.81M89.83M42.86M23.48M
Selling and marketing
0000
Total operating expenses
169.34M108.55M53.24M32.20M
Operating income
-163.91M-108.55M-52.28M-29.20M
Other income (expenses), net
-2.04M-3.75M-967K553K
Income before tax
-165.96M-112.31M-53.25M-28.64M
Income tax expense
1.09M2.41M1.02M317K
Net income
-167.05M-114.72M-54.27M-28.96M
Earnings per share
Basic EPS
-1.27-0.93-0.56-0.3
Diluted EPS
-1.27-0.93-0.56-0.3
Data sourceData sourceData source